Abstract
Leishmania (L.) tropica is a causative agent of cutaneous and occasionally visceral or viscerotropic leishmaniasis in humans. The dose of parasites influences the course and outcome of disease in some Leishmania species. The effect of parasite dose on L. tropica infection in an experimental model was studied in the current paper. High and low doses of L. tropica were used for ear infection of BALB/c mice and lesion development, parasite load, and cytokine responses were assessed. L. major infection was used for comparison. Pre-infected mice were challenged in the footpad by a fixed high dose of L. tropica, and immune response and protection level were evaluated. High dose L. tropica infection in comparison to low dose results in higher lesion diameters, higher load of parasite in draining lymph node, higher levels of interferon-γ and interleukin-10, dissemination of parasite to spleen, and induction of protection against further L. tropica challenge. Comparison of L. tropica with L. major showed that L. tropica results in lower lesion diameters, more potential for growth in lymph nodes at early phases of infection, parasite dissemination to spleen, lower levels of IL-10, and a permanent lower cytokine response against low parasite dose in comparison to high dose. Our findings suggest that for L. tropica infection, only the high dose results in visceralization of the parasite and protection against further challenge of L. tropica. Therefore, the parasite dose may be an important factor in pathogenesis and immunity in L. tropica infection.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Leishmaniasis is a disease that is caused by infection by Leishmania (L.) parasites. There are different forms of leishmaniasis. The most common forms are cutaneous leishmaniasis, which causes skin sores, and visceral leishmaniasis, which affects internal organs (spleen, liver, and bone marrow). L. tropica is a causative agent of cutaneous leishmaniasis in humans. It can occasionally be a causative agent of visceral or viscerotropic leishmaniasis in humans (Alborzi et al. 2006; Eroglu et al. 2015; Magill et al. 1993). The dose of parasites may influence the course and outcome of infection caused by some Leishmania species. The infectious dose is especially important in experimental models of Leishmania infection because the traditional infectious dose in experimental animal models has been about one million parasites while the infectious dose in natural transmission is much less, about < 600 parasites in 75% of sand fly bites (Kimblin et al. 2008; Warburg and Schlein 1986). Thus, the high infectious dose of millions may not represent what happens in the natural transmission of the disease. The effect of infectious dose of some Leishmania species has been studied in experimental models (Bastien and Killick-Kendrick 1992; Compton and Farrell 2002; Doherty and Coffman 1996; Kaur et al. 2008; Lira et al. 2000; Menon and Bretscher 1998; Oliveira et al. 2012; Ribeiro-Gomes et al. 2014; Ribeiro-Romao et al. 2014; Uzonna et al. 2004). Our previous report is the only study available for the effect of infectious dose in L. tropica infection, in which we mainly focused on antibody response of BALB/c mice (Rostamian et al. 2017). The present report is the continuation of our previous report which elucidates the effect of infectious dose in other aspects of L. tropica infection including parasite load, dissemination of the parasite to visceral organs, cytokine responses, and protection against further infection (challenge). In addition, L. tropica infection was compared to L. major in the current study to present a more comprehensive experimental model of L. tropica infection.
Materials and methods
Mice
Female BALB/c mice, 5–7 weeks old, were purchased from the Pasteur Institute of Iran and maintained under conventional conditions in the animal care facility. Mice were housed in cages in a ventilated room with unlimited access to food and water under a 12-h light and 12-h darkness cycle. Mice were euthanized by cervical dislocation before removal of the spleen and lymph nodes. All animal experiments were approved by Ethics Committee of the Pasteur Institute of Iran (license number 95/0201/20704). Caring for and using the mice in this study were done according to “Iranian national ethical guidelines: How to work with laboratory animals.”
Parasite
The L. tropica strain MHOM/AF/88/KK27 is a cutaneous L. tropica isolate from Afghanistan and was initially described by Dr. R. Killick-Kendrick. It was provided for this study as a gift from Dr. D. Sacks (Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA). The L. major strain MRHO/IR/75/ER is an L. major isolate from Iran and was a gift from Dr. M. Mohebali (School of Public Health, Tehran University of Medical Sciences, Tehran, Iran). Parasites were cultured and their species were confirmed as reported elsewhere (Mahmoudzadeh-Niknam et al. 2011a, b). Virulence of parasites was preserved by injection of the parasite to BALB/c mice and its retrieval from mice. The in vitro cultivation of the parasite in Novy Mac Neal Nicolle (NNN) media was kept to less than three passages after isolation from mice to maintain virulence. Stationary-phase promastigotes were used for infection.
Route of infection
Primary infection was injected by the intradermal route into the pinna of the ear and the challenge subcutaneously into the foot pad. The pinna was selected because this site is exclusively intradermal with no subcutaneous tissue.
Dose of parasites
Primary infection was performed by two doses of low (103 parasites/mouse) and high (106 parasites/mouse). The low dose of 103 promastigotes was used in order to simulate the natural transmission. The high dose of 106 was used to clarify possible differences between the high and low doses and also to make our data comparable to many published studies using the high dose. These two doses have been used in many studies involving Leishmania parasites. Challenging infection was performed by a fixed dose of 106 parasites/mouse.
Antigen preparation
Soluble Leishmania antigen (SLA) was prepared from L. tropica strain MHOM/AF/88/KK27. The parasite was cultured in liquid media consisting of RPMI-1640, 10% FBS, 200 mM l-glutamine, penicillin (100 IU/ml), and streptomycin (100 μg/ml). Stationary-phase promastigotes were harvested, washed three times with PBS, passed five cycles of freeze (in liquid nitrogen) and thaw (in 37 °C), and centrifuged 13,000×g for 5 min, and the supernatant was collected as SLA. Protein content was assayed by the Bradford method (Simonian and Smith 2006). SLA was aliquoted and stored in − 80 °C. A single preparation of SLA from L. tropica was used for all in vitro stimulation assays in our study. This approach was used with the assumption of sufficient similarity between epitope contents of SLA from L. tropica and L. major.
Lesion measurement
The course of infection was monitored by bi-weekly measurement of thickness of ear or footpad by a dial-gauge caliper (Mitutoyu, Kawasaki, Kanagawa, Japan). Increase in thickness was calculated through subtraction of thickness of infected ear or footpad from thickness of contra lateral uninfected ear or footpad.
Parasite load assay
Parasite load in draining lymph node and spleen were quantified by limiting dilution assay (Sacks and Melby 2015). The assay is briefly as follows: single cell suspensions are made from draining lymph node or spleen and diluted in the liquid phase of NNN medium. Two- or fourfold serial dilutions were performed to extinction of parasite growth. Assays were performed in triplicate. Parasite load per total lymph node and spleen was calculated from the highest dilution at which promastigotes can be grown out. Parasite load was determined for each individual mouse. Geometric mean titer of each experimental group was used for comparison between the groups.
Cytokine assay
Draining lymph nodes (auricular lymph node in ear of infected mice and popliteal lymph node in footpad infected mice) were removed from mice. Single cell suspensions were made from draining lymph nodes by passing them through a stainless steel mesh. Cells were grown in culture media and stimulated by SLA (10 μg/ml). The same SLA prepared from L. tropica was used for all in vitro stimulation. Culture media was composed of RMPI-1640, fetal bovine serum (10%), penicillin (100 IU/ml), streptomycin (100 μg/ml), L. glutamine (200 mM), and 2-mercapto ethanol (0.05 mM). Cell stimulated by concanavalin A (2 μg/ml) was used as positive control. Unstimulated cells were used as negative control. Culture supernatants were harvested after 72 h and aliquots were stored at − 80°C. Levels of cytokines of interferon-γ (IFN-γ) and interleukin-10 (IL-10) were assayed in the supernatant by commercial kits from e-bioscience and R&D according to manufacturer’s instructions. The detection limit of the ELISA kits for both IFN-γ and IL-10 was 31.2–2000 pg/ml.
Study design
The study consisted of the following experimental groups (12–15 mice per group): L. tropica high dose, L. tropica low dose, L. major high dose, L. major low dose, and naive mice. Primary infection was performed by intradermal injection into ear pinna (Sacks and Melby 2015). The low dose of 103 parasites/mouse and the high dose of 106 parasites/mouse were used for primary infection. L. tropica infection was compared to L. major infection in the ear pinna using the same low and high parasite doses and the following criteria were assessed: lesion development, parasite load of lymph node and spleen, and cytokine levels. The study was carried out in two independent experiments and results of one representative experiment are shown. Pre-infected mice (low and high doses of L. tropica and low dose of L. major) as well as naive mice were challenged in the footpad by 106 L. tropica stationary promastigotes 6 months after primary infection. Protection induced by primary infection of L. major or L. tropica against L. tropica challenge was evaluated by assessing lesion diameter, parasite load, and cytokine levels.
Statistical analysis
One- or two-tailed Student’s t test was used for comparison of thicknesses, parasite loads, and cytokine amounts between different experimental groups using the GraphPad Prism 6.0 for Windows (GraphPad Software Inc., San Diego, CA, USA). P values equal or lower than 0.05 were considered significant.
Results
Effect of infectious dose on pathogenicity
As published in our previous report (Rostamian et al. 2017), lesions developed from a high dose of L. major or L. tropica were significantly larger than those caused by a low dose from the same species (P < 0.05) and at equivalent infectious doses, L. major infection in comparison to L. tropica results in higher lesion diameter showing more pathogenesis (P < 0.05) (Fig. 1).
Our results (Fig. 2a) show that high dose in comparison to low dose of either L. major or L. tropica results in significantly higher load of parasite in draining lymph node at all intervals studied (1 week, 1 month, and 4 months after infection) (P < 0.05). An interesting finding of our study is that the high dose of L. tropica, in comparison to the high dose of L. major, resulted in significantly higher parasite load in lymph nodes at 1 week as well as at 1 month after infection (P < 0.05). The difference between L. tropica and L. major became significant for both high and low doses at 1 month after infection (P < 0.05). However, there is no significant difference between L. tropica and L. major of both low and high doses at 4 months after infection. Our study showed that only L. tropica at 4 months after infection disseminates to spleen. As shown in Fig. 2b, there is no parasite growth in the spleen of all experimental groups except for the high-dose group of L. tropica at 4 months after infection.
Effect of infectious doses on immune response
IFN-γ response
The data for L. major showed that high dose in comparison to low dose results in higher levels of IFN-γ at 1 week and 1 month after infection (Fig. 3a). However, there is no significant difference between high and low doses of L. major at 4 months (Fig. 3a). Comparison of IFN-γ response against high and low doses of L. tropica showed that higher levels of IFN-γ is produced against high dose in comparison to low dose at all intervals post-infection (Fig. 3a).
There was no significant difference between IFN-γ levels in response to L. major and L. tropica infection at similar infectious doses (Fig. 3a).
IL-10 response
Higher levels of IL-10 were produced in response to high dose of L. major in comparison to low dose at 1 week and 1 month post-infection (Fig. 3b). However, at 4 months after infection, there are similar levels of IL-10 against high and low doses of L. major (Fig. 3b). Similar late-phase IL-10 response to low and high doses of L. major is concordant with similar late-phase IFN-γ response to low and high doses of this parasite as mentioned above.
As shown in Fig. 3b, higher levels of IL-10 are produced against high dose of L. tropica in comparison to low dose in all post-infection intervals. This pattern of IL-10 response against L. tropica is different from that of IL-10 response against L. major as mentioned above in which similar levels of IL-10 are produced against low and high doses at 4-month post-infection interval.
Considering high-dose infection, higher level of IL-10 is produced in response to L. major in comparison to L. tropica at 1 month post-infection (P < 0.05) and this difference wanes at 4 months post-infection. Regarding low-dose infection, no significant difference was observed between the two Leishmania species (Fig. 3b).
Effect of infectious dose on protection against L. tropica challenge
Mice infected by different doses of L. tropica were challenged by L. tropica 6 months after primary infection, in order to assess the homologous protective effect of primary infection of L. tropica against the secondary infection of the same species. Mice infected by low dose of L. major were used as a control group which already had had a Th2 response and challenged by L. tropica in order to assess how the primary L. major infection affects the secondary L. tropica infection. Primary infections were in the ear by injection of high (106) and low (103) doses of L. tropica and low (103) dose of L. major. The secondary (challenge) infection was in the footpad by injection of 106 L. tropica. Footpad diameter increase was measured up to 10 months after challenge. The results showed that footpad lesion diameter of L. major pre-infected mice were significantly higher than lesion diameter of naïve mice showing that previous infection by L. major induces an exacerbation in BALB/c mice as was anticipated (Sacks and Noben-Trauth 2002) (Fig. 4a). On the other hand, lesions of mice pre-infected with high (106) dose of L. tropica were significantly lower than naïve mice showing that a protective immunity was induced at the site of injection by high dose of L. tropica pre-infection (Fig. 4a). Mice pre-infected by low (103) dose of L. tropica showed lesion diameter similar to the naïve mice (Fig. 4a) showing that the immune response of low-dose pre-infected mice has not been sufficiently shifted to a protective response. Lymph node parasite load after L. tropica challenge was significantly lower only in mice pre-infected by high dose of L. tropica in comparison to naïve mice (Fig. 4b). It is noteworthy that during the 10-month period after L. tropica challenge in the footpad, the ear lesions of primary infections of high and low doses of L. tropica reduced to baseline level but the ear lesion of primary infection of L. major increased and resulted in necrosis of the ear.
Levels of IFN-γ response after challenge showed that while all pre-infected groups have significantly higher IFN-γ in comparison to the naïve group, there was no significant difference between all pre-infected groups (Fig. 5a). Results of IL-10 response after challenge showed significantly higher levels of this cytokine in the “low-dose L. major” group in comparison to all other experimental groups (Fig. 5b).
Discussion
In this research, we have concentrated on a variable of the experimental model of diseases caused by L. tropica: “infectious dose.” The dose of antigen is an important factor that influences the type of immune response. Results of primary culture of naïve CD4+ T cells showed that development of Th1 or Th2 type of CD4+ T cells strictly depends on the dose of antigen (Hosken et al. 1995).
This study aimed to determine whether the infectious dose of L. tropica affects the pathology of this infection. It elucidates the effect of the infectious dose on parasite load, dissemination of the parasite to visceral organs, cytokine responses, and protection against further infection (challenge).We used L. major as a control species because pathogenicity and the immune response against this Leishmania species have been already studied in detail (Sacks and Noben-Trauth 2002). Our results related to L. major infection were as predicted and were completely consistent with previous report (Sacks and Melby 2015).
L. tropica infections (both low and high doses) displayed a chronic self-healing infection and are in agreement with the previous reports (Lira et al. 1998; Mahmoudzadeh-Niknam et al. 2007). Results of lesion diameter and parasite load show, as predicted, that decreasing the infectious dose of L. tropica decreases the pathogenicity of this parasite species in BALB/c mice.
Dissemination of L. tropica into the spleen (visceralization) is an indication of pathology of this parasite. Our results showed that dissemination of the parasite to the spleen occurs only in the high-dose infection at 4 months after infection. This result indicates that increasing the dose of L. tropica increases the parasite pathogenesis. Dissemination of the parasite into the spleen was observed only for L. tropica and not for L. major. This suggests that L. tropica is biologically more suited to dissemination than L. major. This is reflective of the fact that dissemination of human L. tropica but not human L. major has been described (Alborzi et al. 2006; Eroglu et al. 2015).
An important finding of our study is that immune response against the low dose of L. tropica is always lower than immune response against high dose of this parasite and this difference remained up to the end of our study. In other words, regarding the immune response, there is a significant difference between low-dose and high-dose infections which is maintained in all phases of infection. Higher immune response against higher dose of L. tropica is concordant with our previous report that showed antibody titer against high dose of L. tropica infection is significantly higher than the antibody titer against the low dose (Rostamian et al. 2017). Comparison of L. tropica data with those of L. major shows that the difference between immune responses against low and high doses of L. tropica is not valid for L. major infection, because low- and high-dose infections of L. major result in similar cytokine levels at later phase of infection.
IL-10 is a cytokine that has potent deactivating effects on IFN-γ-mediated killing by macrophages (Bogdan and Nathan 1993; Sacks and Anderson 2004). Higher levels of IL-10 in L. major-infected mice in comparison to L. tropica suggests that this cytokine may be associated with the higher pathology of L. major in comparison to L. tropica in BALB/c mice. These findings confirm previous reports (Chatelain et al. 1999; Kane and Mosser 2001; Mahmoudzadeh-Niknam et al. 2011b; Noben-Trauth et al. 2003; Stober et al. 2005) that IL-10 is associated with exacerbation of L. major infection in BALB/c mice. However, in contrast to L. major, it is not clear how IL-10 affects pathogenesis and immunity against L. tropica, although higher levels of IL-10 were observed in response to high dose in comparison to low-dose L. tropica. The role of IL-10 in pathogenesis and immunity in L. tropica infection needs further studies.
Here, we showed the effect of primary L. major infection on exacerbation of secondary L. tropica infection. These results show that pre-infection by L. major induces a disease-promoting response as was anticipated (Sacks and Noben-Trauth 2002). On the contrary, high dose of L. tropica results in protection against further L. tropica challenge. However, pre-infection by low dose of L. tropica did not result in the protection against L. tropica challenge as shown by similar lesion diameters in this group in comparison to naïve mice. Results of lesion diameter, parasite load, and IL-10 response showed general concordance: higher lesion diameter was associated with higher parasite load and higher IL-10 response. These results confirm the validity of our findings. These results may show that the immune response of low-dose L. tropica pre-infected mice is not sufficiently powerful to alter the lesion development of L. tropica challenge, but more scrutinizing studies are needed in this case. Our results regarding the sharp difference between high and low doses in induction of protective immunity are concordant with another report, in which a high dose, but not a low dose, of L. chagasi promastigotes induces protective immunity against challenge infection with L. chagasi (Streit et al. 2001).
The less protective immunity induced by a low dose in comparison to a high dose of L. tropica suggests that the infectious dose has an important role in L. tropica infection. On the other hand, only the high dose of L. tropica showed the visceral growth in our study that again underscores the important role of the infectious dose in certain phenomenon associated with pathogenicity of L. tropica.
It is noteworthy that sand flies become infected in nature with different doses of Leishmania parasites. Also, transmission of different Leishmania doses (from high to low doses) to experimental animals after sand fly bites has been reported (reviewed in Courtenay et al. (2017)). Due to these varying initiating doses of sand fly bites, here, we used needle injection to more accurately determine the amount of parasites, although the sand fly bite procedure is more similar to natural infection. In spite of this limitation, the results of the present study may help to broaden the view of dose effect on cutaneous leishmaniasis.
Conclusion
Results of this study reveal that some phenotypes of L. tropica infection in BALB/c mice experimental models depend on the infectious dose. These phenotypes include visceralization of parasite to spleen, induction of high levels of cytokine, and protection against challenging infection. Our results also reveal substantial differences between L. tropica and L. major infections which may be helpful for elucidation of the complex profile of L. tropica infections.
References
Alborzi A, Rasouli M, Shamsizadeh A (2006) Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg 74:306–307
Bastien P, Killick-Kendrick R (1992) Leishmania tropica infection in hamsters and a review of the animal pathogenicity of this species. Exp Parasitol 75:433–441
Bogdan C, Nathan C (1993) Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 685:713–739
Chatelain R, Mauze S, Coffman RL (1999) Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 21:211–218
Compton HL, Farrell JP (2002) CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J Immunol 168:1302–1308
Courtenay O, Peters NC, Rogers ME, Bern C (2017) Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control. PLoS Pathog 13:e1006571
Doherty TM, Coffman RL (1996) Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol 84:124–135
Eroglu F, Koltas IS, Alabaz D, Uzun S, Karakas M (2015) Clinical manifestations and genetic variation of Leishmania infantum and Leishmania tropica in Southern Turkey. Exp Parasitol 154:67–74
Hosken NA, Shibuya K, Heath AW, Murphy KM, O’Garra A (1995) The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 182:1579–1584
Kane MM, Mosser DM (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166:1141–1147
Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V (2008) Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413–1419
Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, Fay MP, Kamhawi S, Sacks D (2008) Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci U S A 105:10125–10130
Lira R, Mendez S, Carrera L, Jaffe C, Neva F, Sacks D (1998) Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 89:331–342
Lira R, Doherty M, Modi G, Sacks D (2000) Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect Immun 68:5176–5182
Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN (1993) Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328:1383–1387
Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D (2007) Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. Korean J Parasitol 45:247–253
Mahmoudzadeh-Niknam H, Abrishami F, Doroudian M, Moradi M, Alimohammadian M, Parvizi P, Hatam G, Mohebali M, Khalaj V (2011a) The problem of mixing up of Leishmania isolates in the laboratory: suggestion of ITS1 gene sequencing for verification of species. Iran J Parasitol 6:41–48
Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D (2011b) Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice. Exp Parasitol 127:448–453
Menon JN, Bretscher PA (1998) Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur J Immunol 28:4020–4028
Noben-Trauth N, Lira R, Nagase H, Paul WE, Sacks DL (2003) The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170:5152–5158
Oliveira DM, Costa MA, Chavez-Fumagalli MA, Valadares DG, Duarte MC, Costa LE, Martins VT, Gomes RF, Melo MN, Soto M, Tavares CA, Coelho EA (2012) Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites. Parasitol Res 110:1277–1285
Ribeiro-Gomes FL, Roma EH, Carneiro MB, Doria NA, Sacks DL, Peters NC (2014) Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major. Infect Immun 82:2713–2727
Ribeiro-Romao RP, Moreira OC, Osorio EY, Cysne-Finkelstein L, Gomes-Silva A, Valverde JG, Pirmez C, Da-Cruz AM, Pinto EF (2014) Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations. Infect Immun 82:5203–5213
Rostamian M, Sohrabi S, Kavosifard H, Niknam HM (2017) Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice. J Microbiol Immunol Infect 50:160–166
Sacks D, Anderson C (2004) Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol Rev 201:225–238
Sacks DL, Melby PC (2015) Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol 108:1921–1924
Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845–858
Simonian MH, Smith JA (2006) Spectrophotometric and colorimetric determination of protein concentration. Curr Protoc Mol Biol Chapter 10:Unit 10 11A
Stober CB, Lange UG, Roberts MT, Alcami A, Blackwell JM (2005) IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175:2517–2524
Streit JA, Recker TJ, Filho FG, Beverley SM, Wilson ME (2001) Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms. J Immunol 166:1921–1929
Uzonna JE, Joyce KL, Scott P (2004) Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med 199:1559–1566
Warburg A, Schlein Y (1986) The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. Am J Trop Med Hyg 35:926–930
Acknowledgements
Critical readings of this paper by Mary E. Wilson (University of Iowa, Iowa City, USA) and Mohammad H. Alimohammadian (Pasteur Institute of Iran, Tehran, Iran) are highly appreciated.
Funding
This research received financial support from PhD scholarship to M. Rostamian, Pasteur Institute of Iran (Research project No. 595), and Iran National Science Foundation (grant No. 93035899).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Rostamian, M., Jafari, D., Abolghazi, M. et al. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model. Parasitol Res 117, 2949–2956 (2018). https://doi.org/10.1007/s00436-018-5991-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-018-5991-7